LifeStance Health Group, Inc. LFST
11.84
0.04
0.34%
as of 25 Sep
- Market cap
- $4.5B
- P/E
- 89.0×
Follow LFST
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 3.43% | 1.58% | 0.65% | (0.62%) |
+8 more TTM periods Free account |
|
| 2.34% | 1.09% | 0.45% | (0.43%) | ||
ROIC |
3.25% | 1.81% | 0.98% | 0.29% | |
Return on Tangible Assets |
18.89% | 8.35% | 2.97% | (3.10%) | |
Average Days of Receivables |
25.56 | 30.01 | 24.53 | 32.31 | |
Free Cash Flow per Share |
0.45 | 0.37 | 0.29 | 0.31 | |
Free Cash Flow |
173.91 | 142.63 | 110.03 | 119.39 | |
Capital Expenditures |
(43.96) | (39.72) | (36.12) | (31.51) | |
Piotroski F-Score |
7.00 | 8.00 | 8.00 | 7.00 | |
| Other line items | |||||
Cash ROIC |
11.10% | 9.43% | 7.18% | 7.68% | |
Accounts Receivable Turnover |
13.18 | 11.35 | 12.52 | 9.80 | |
Accounts Payable Turnover |
111.75 | 172.13 | 144.15 | 94.72 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
3.83 | 1.55 | 2.32 | 4.83 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.24) | (0.31) | (0.22) | (0.22) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
25.17% | 25.96% | 26.83% | 27.87% | |
Share Based Compensation of Revenue |
4.41% | 4.77% | 5.24% | 5.42% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
4.31 | 7.86 | 15.12 | (16.55) | |
Depreciation/Fixed assets |
0.34 | 0.34 | 0.35 | 0.35 | |
Capex/Depreciation |
(0.79) | (0.72) | (0.65) | (0.55) | |
Revenue per Share |
4.13 | 3.86 | 3.69 | 3.53 | |
Operating CF per Share |
0.57 | 0.47 | 0.38 | 0.39 | |
Capex per Share |
(0.11) | (0.10) | (0.09) | (0.08) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.02 | |
Net Profit Margin |
3.19% | 1.55% | 0.68% | (0.67%) |
Columns are period end dates